Clinical trials
Phase 4 Atherosclerosis trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 3 |
| 2012 | 4 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 4 |
| 2022 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| HaEmek Medical Center, Israel | 2 |
| Medical University of Vienna | 2 |
| Tehran University of Medical Sciences | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Azienda Unita Sanitaria Locale di Piacenza | 1 |
| Baylor College of Medicine | 1 |
| Beijing Anzhen Hospital | 1 |
| Canadian Medical and Surgical Knowledge Translation Research Group | 1 |
| Chinese PLA General Hospital | 1 |
| Cordis US Corp. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 41 |
| Cardiovascular Diseases | 8 |
| Coronary Artery Disease | 7 |
| Inflammation | 6 |
| Diabetes Mellitus, Type 2 | 5 |
| Peripheral Arterial Disease | 5 |
| Coronary Disease | 3 |
| Hyperlipidemias | 3 |
| Hypertension | 3 |
| Renal Artery Obstruction | 3 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.